45 results
424B3
SKYE
Skye Bioscience Inc
10 Apr 24
Prospectus supplement
4:40pm
to achieve our goals, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit … observation period. The main goal is to measure the percentage of weight loss by week 26, with secondary goals assessing changes in waist size, body
8-K
EX-99.3
5rrt1ss ie
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
DEFM14A
ubz11bq3s bg4s1vj
31 Aug 22
Proxy related to merger
5:19pm
PREM14A
1o9ruu0kiu1gblkwc lw
15 Aug 22
Preliminary proxy related to merger
12:00am
8-K
wvkitwwyaszat5128860
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-99.1
7qbagivhlzx4bo
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-99.1
a81 0c6r88
20 Dec 21
Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer
5:25pm
8-K
EX-10.1
q5x3y ida
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
424B3
3a0p a4iwcc
2 Mar 21
Prospectus supplement
12:00am
424B4
mchakomyf9w50e o6
3 Aug 20
Prospectus supplement with pricing info
5:02pm